Akawi Nadia, McRae Jeremy, Ansari Morad, Balasubramanian Meena, Blyth Moira, Brady Angela F, Clayton Stephen, Cole Trevor, Deshpande Charu, Fitzgerald Tomas W, Foulds Nicola, Francis Richard, Gabriel George, Gerety Sebastian S, Goodship Judith, Hobson Emma, Jones Wendy D, Joss Shelagh, King Daniel, Klena Nikolai, Kumar Ajith, Lees Melissa, Lelliott Chris, Lord Jenny, McMullan Dominic, O'Regan Mary, Osio Deborah, Piombo Virginia, Prigmore Elena, Rajan Diana, Rosser Elisabeth, Sifrim Alejandro, Smith Audrey, Swaminathan Ganesh J, Turnpenny Peter, Whitworth James, Wright Caroline F, Firth Helen V, Barrett Jeffrey C, Lo Cecilia W, FitzPatrick David R, Hurles Matthew E
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Medical Research Council (MRC) Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine (IGMM), University of Edinburgh, Western General Hospital, Edinburgh, UK.
Nat Genet. 2015 Nov;47(11):1363-9. doi: 10.1038/ng.3410. Epub 2015 Oct 5.
Discovery of most autosomal recessive disease-associated genes has involved analysis of large, often consanguineous multiplex families or small cohorts of unrelated individuals with a well-defined clinical condition. Discovery of new dominant causes of rare, genetically heterogeneous developmental disorders has been revolutionized by exome analysis of large cohorts of phenotypically diverse parent-offspring trios. Here we analyzed 4,125 families with diverse, rare and genetically heterogeneous developmental disorders and identified four new autosomal recessive disorders. These four disorders were identified by integrating Mendelian filtering (selecting probands with rare, biallelic and putatively damaging variants in the same gene) with statistical assessments of (i) the likelihood of sampling the observed genotypes from the general population and (ii) the phenotypic similarity of patients with recessive variants in the same candidate gene. This new paradigm promises to catalyze the discovery of novel recessive disorders, especially those with less consistent or nonspecific clinical presentations and those caused predominantly by compound heterozygous genotypes.
大多数常染色体隐性疾病相关基因的发现涉及对大型、通常为近亲的多重家庭或患有明确临床病症的无关个体的小队列进行分析。对大量表型多样的亲代-子代三联体进行外显子组分析,彻底改变了罕见的、基因异质性发育障碍新显性病因的发现。在此,我们分析了4125个患有多样、罕见且基因异质性发育障碍的家庭,并确定了四种新的常染色体隐性疾病。这四种疾病是通过将孟德尔筛选(选择在同一基因中具有罕见、双等位基因且可能有害变异的先证者)与以下统计评估相结合而确定的:(i) 从一般人群中抽样观察到的基因型的可能性,以及 (ii) 同一候选基因中具有隐性变异的患者的表型相似性。这种新范式有望促进新型隐性疾病的发现,尤其是那些临床表现不太一致或不具有特异性的疾病,以及那些主要由复合杂合基因型引起的疾病。